Context Therapeutics Presents CTIM-76 Phase 1 Trial in Progress at ASCO 2025
Context Therapeutics Inc. (NASDAQ:CNTX) is one of the best penny stocks under $1 to buy now.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Luminus Management Jonathan Barrett And Paul Segal | 0 | $0 | 0% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.70 | 100,000 | $70,080.00 | 920,190 | 2025-06-09 | Filing | |
| $0.58 | 20,000 | $11,520.00 | 29,000 | 2025-06-06 | Filing | |
| $0.64 | 40,010 | $25,486.37 | 80,010 | 2025-06-06 | Filing | |
| $0.84 | 5,823 | $4,900.05 | 159,701 | 2023-02-21 | Filing | |
| $0.87 | 5,606 | $4,900.77 | 153,878 | 2023-02-13 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 92,804 | $89,909 | 0% | |
| 2. | 20,000 | $19,376 | 0% |